Any measurement in which the number of individuals in a study population that display leukemia, any of a group of progressive, malignant diseases of the blood-forming organs, marked by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow, at a point in time or develop leukemia within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio.
lymphoma incidence/prevalence measurement +
nervous system disease incidence/prevalence measurement +
organ non-tumorous lesion incidence/prevalence measurement +
organ tumorous lesion incidence/prevalence measurement +
percentage of study population developing ascites during a period of time
percentage of study population developing extra-hepatic metastases during a period of time
percentage of study population developing peritoneal carcinomatosis during a period of time
percentage of study population developing radiation pneumonitis during a period of time
percentage of study population developing radiation-induced bone marrow disease during a period of time